Antioxidant use in Friedreich ataxia

Antioxidant use in Friedreich ataxia

Item
http://www.wikidata.org/entity/Q36517343
Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxiaIdebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout miceNQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levelsMeasuring the rate of progression in Friedreich ataxia: implications for clinical trial design.Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.Redox processes in neurodegenerative disease involving reactive oxygen speciesDrug development for rare mitochondrial disordersCardiac involvement in hereditary ataxiasChildhood ataxia: clinical features, pathogenesis, key unanswered questions, and future directions.Predictors of progression in patients with Friedreich ataxiaUnderstanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches.A review of Friedreich ataxia clinical trial results.Milestones in Friedreich ataxia: more than a century and still learning.Therapeutic approaches for the treatment of Friedreich's ataxia.Pharmacological therapeutics in Friedreich ataxia: the present state.Idebenone in Friedreich's ataxia
P2860

Antioxidant use in Friedreich ataxia

Item
http://www.wikidata.org/entity/Q36517343
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antioxidant use in Friedreich ataxia
@ast
Antioxidant use in Friedreich ataxia
@en
type
label
Antioxidant use in Friedreich ataxia
@ast
Antioxidant use in Friedreich ataxia
@en
prefLabel
Antioxidant use in Friedreich ataxia
@ast
Antioxidant use in Friedreich ataxia
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Antioxidant use in Friedreich ataxia
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932